Humira is a human monoclonal antibody. It works by blocking tumor necrosis factor alpha (TNF-alpha), a cytokine that plays a ...

Adalimumab (brand name Humira) is an anti-TNF alpha agent that can be used for moderate-to-severe ulcerative colitis. While ...

Tumor necrosis factor (TNF)-alpha, a proinflammatory cytokine, has been implicated in the pathogenesis of AD. Objective: To investigate the use of a biologic TNF-alpha inhibitor, etanercept was ...

Humira’s success is down to its incredible versatility – an anti-TNF drug, it is approved in a range of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis and Crohn’s ...